Medicines A–Z
A
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Atropine suplhate 1% single use drops |
Specialist ophthalmologist recommendation |
|
|
|
Atropine tablets |
For Myaesthenia Gravis only |
|
|
Avacopan (Tavneos®) | ||
|
|
Avalglucosidase | ||
|
|
Avatrombopag | ||
|
|
Avatrombopag (Doptelet®) | ||
|
|
Aveeno cream |
Amber - oncology use Green - paediatrics only |
|
|
|
Avelumab (Bavencio®) | ||
|
|
Aviptadil 25mcg / Phentolamine 2mg intracavernosal injection (Invicorp®) |
Approved on formulary December 2017. Specialist initiation. Third line after oral PDE-5 inhibitors failed and patient not responding to or intolerant of alprostadil. To be reviewed within 12 months to assess alprostadil supply issues and patent expiry |
|
|
|
Axicabtagene ciloleucel (Yescarta®) |
|
